61Indexed trials
mesh condition
Parkinson Disease 4, Autosomal Dominant Lewy Body
Intelligence
Parkinson Disease 4, Autosomal Dominant Lewy Body intelligence: 61 indexed trials, 22 recruiting studies, 16 sponsors across 55 countries.
22Recruiting
16Sponsors
55Countries
Leading sponsors
Merck Sharp & Dohme LLC4416 recruiting
Incyte Corporation30 recruiting
Invicro10 recruiting
Loren Mell, MD11 recruiting
MODAG GmbH10 recruiting
Michael J. Fox Foundation for Parkinson's Research10 recruiting
NYU Langone Health10 recruiting
Peking University First Hospital11 recruiting
Shandong New Time Pharmaceutical Co., LTD10 recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University11 recruiting
Tianjin Medical University11 recruiting
University Hospital Schleswig-Holstein11 recruiting
Geographic activity
United States41trials
Spain31trials
Canada27trials
Germany25trials
Italy25trials
Australia25trials
South Korea25trials
France24trials
Chile24trials
Poland24trials
Israel23trials
Japan22trials
Leading interventions
Pembrolizumab32trials
Cisplatin13trials
Carboplatin11trials
Paclitaxel6trials
pembrolizumab6trials
Docetaxel5trials
Pemetrexed4trials
Gemcitabine4trials
Epacadostat3trials
Olaparib3trials
Oxaliplatin3trials
Cetuximab3trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.